Dealmaker's Digest: A Top 10 Bulletin - February 2025

Alert
February 2025
3 minutes

In Dealmaker’s Digest, read the top 10 latest developments in global transactions. We offer insights into M&A activity across industries and borders. To receive our M&A thought leadership, please join our mailing list.

Key Takeaways

  • While global M&A activity in January declined from most December metrics, monthly deal value and count remained consistent year-over-year, buoyed by sponsor-led transactions (which were up 55% by value vs. January 2024). 
  • Hostile and unsolicited bids jumped in January, significantly outpacing hostile activity trendlines in recent years. 
  • Acquisition premiums increased moderately month-over-month, reversing a broad decline of premium percentages over the past two years.

Global M&A Activity Update

Deal Value Trends

Aggregate global monthly deal value1 in January fell 18%, or about $60 billion, from December. Total deal value was up slightly (6%) year-over-year.

Transactions involving strategic buyers in January decreased 20% by deal value from December and 12% year-over-year.

Financial, or sponsor, buyer transactions declined 17% in January, barely exceeding $100 billion for the month. However, sponsor buyer deal value was up significantly (55%) year-over-year.

Deal Count Trends

Global deal count decreased 13% in January from December but held steady year-over-year, down just 1%.

Strategic buyer deal count in January fell 20% from December but held steady year-over-year, with a 0% change.

Sponsor buyer deal count in January remained consistent both month-over-month (up just 1%) and year-over-year (down only 2%).

Active M&A Industries (U.S. Targets)

By Deal Count

  • The software industry remained at the top for U.S. M&A activity by deal count in January, continuing its streak as the leading industry by volume, with more than twice as many deals as the runner-up.
  • Services-based industries continue to remain active, with financial services and other professional services rounding out the top three sectors in January by deal count.

Chart showing software, services (other) and financial services as the top three leading industries by deal count.

By Deal Value

  • The energy industry topped the charts by deal value in January, with a $16 billion+ deal announced by Constellation, highlighted below.
  • Software took second place in January for deal value, with three of the 10 largest U.S. deals for the month involving a target in the software sector. Targets in the biotech industry came in close behind at third.

Chart showing energy, software and biotechnology as the top three leading industries by deal value.

January Blockbuster Deals

Largest U.S. Energy Deal

Constellation Energy Corporation has agreed to acquire Calpine Corporation for a mix of cash and stock with total equity value of approximately $16.4 billion.


Largest U.S. Biotech Deal

Johnson & Johnson has agreed to acquire Intra-Cellular Therapies, Inc. in an all-cash transaction with equity value of approximately $14.6 billion.

Crossborder Corner

Inbound U.S. M&A Activity

  • By deal value, inbound U.S. activity rose 34% in January from December’s six-month low. Year-over-year, inbound deal value was up 7%.
  • By deal count, acquisitions of U.S. targets by non-U.S. acquirers increased 27% in January from December’s 10-month low. Year-over-year, inbound deal count held steady, down just 1%.
  • UK-based acquirers undertook the largest number of inbound transactions in January, with 22 deals, followed closely by Canada at 20. Japan trailed in third with six deals.

Outbound U.S. M&A Activity

  • By deal value, outbound activity in January dropped 45% from December but was up 7% year-over-year.
  • By deal count, acquisitions of ex-U.S. targets by U.S. buyers decreased from December to January by 17%. Year-over-year, outbound deal count fell 11%.
  • U.S. acquirers most frequently looked to targets in the UK in January, with 31 transactions. Canada and Ireland trailed with 14 and 11 transactions, respectively.

  1. Unless otherwise noted, charts compiled using Mergermarket data for January 2025 as of February 5, 2025. Aggregate deal values by dollar amount are calculated from the subset of deals with disclosed values.
  2. Medical industry classification principally includes medical devices/technology/services, excluding biotech and pharmaceutical deals.
  3. Charts compiled using Deal Point Data metrics as of February 10, 2025. Premium data based on unaffected premium %s.
For more information, please contact your usual Ropes & Gray attorney or reach out to a member of our M&A team below.